biotech
biotech Articles
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what price.
Published:
Last Updated:
On Thursday, a few companies in the biotech and pharmaceutical industries made substantial runs. In this case it was all downward.
Published:
Last Updated:
On Tuesday, a few biotech companies made substantial runs, either up and down, due to the results of FDA approvals, failed or passed trials and even earnings results.
Published:
Last Updated:
Eleven Biotherapeutics is continuing to rise this week after the company announced the effectiveness of the exclusive licensing deal with Roche.
Published:
Last Updated:
Jefferies searches for growth with reasonable valuations and upside potential. This week's picks are no exception to that rule.
Published:
Last Updated:
A few biohealth companies made absolutely massive runs in Thursday’s session. The companies 24/7 Wall St. has picked stood out from the rest with big moves, all at least up 10%.
Published:
Last Updated:
Investors are now focusing on fundamentals and near-term catalysts that could provide a tailwind for some of the biotech leaders.
Published:
Last Updated:
GW Pharmaceuticals PLC (NASDAQ: GWPH) was seeing some selling pressure after the company reported earnings. Its third quarter loss was actually better than expected, but revenues of $3.1 million...
Published:
Last Updated:
24/7 Wall St. could not help but notice how many analysts on Wall Street have simply abandoned their old upside hopes for Myriad Genetics.
Published:
Last Updated:
The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech stocks.
Published:
Last Updated:
The analysts at Stifel have noted three biotech companies that not only have data that could prove to be huge, but also have stocks that have been absolutely hammered over the past year.
Published:
Last Updated:
According to the CDC, 743 women over 50 gave birth in 2014, which is either a testament to the health of some older women, or a signal of the effectiveness of modern medicine.
Published:
Last Updated:
Though these four large cap biotech stocks are cheap relative to the S&P 500, history says they won’t stay that way.
Published:
Last Updated:
A new report from Wedbush focuses on upcoming catalysts for biotech stocks in the firm's coverage universe. These four have monster potential upside to the posted price targets.
Published:
Last Updated:
According to one analyst, Advaxis shares could still easily more than double, even after news broke that biotech giant Amgen will become its partner.
Published:
Last Updated: